Europe Medical Plastics Market to Reach $22.8 Billion by 2035
Europe medical plastics market is driven by the increasing demand for advanced healthcare devices, rising adoption of disposable medical products, and growing investments in healthcare infrastructure across the region. The expanding use of traditional and engineered plastics in diagnostic instruments, catheters, syringes, implants, surgical instruments, and drug delivery devices is significantly supporting market growth. In addition, advancements in biocompatible and high-performance polymer materials, increasing focus on infection control, and the growing demand for lightweight and cost-effective medical components are accelerating the adoption of medical plastics across the healthcare and pharmaceutical industries in Europe.
Browse the full report description of “Europe Medical Plastics Market Size, Share & Trends Analysis Report by Plastic Type (Traditional Plastics (Polyvinylchloride (PVC), Polyethylene (PE), Polystyrene (PS), Polypropylene (PP), and Silicone), Engineered Plastics (Nylon, Polycarbonate (PC), Polyoxymethylene (POM), Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Polyphenylene Oxide (PPO), and Others), and by Application (Disposables, Diagnostic Instruments, Catheters and Syringes, Implants, Dental Tools, Surgical Instruments, Medical Bags, Drug Delivery Devices, and Others), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/europe-medical-plastics-market
Recyclable medical polypropylene segment is expected to account for a major market share in 2025
Recyclable medical polypropylene materials are expected to hold a major market share in 2025, primarily due to the increasing demand for lightweight, sustainable, and high-performance plastics in healthcare and medical device applications. These materials are widely utilized in medical packaging, diagnostic devices, disposable healthcare products, and pharmaceutical components owing to their durability, chemical resistance, and recyclability advantages. The investment exceeding €100 million announced by Borealis in May 2025 to expand production capacity for recyclable high-melt-strength polypropylene (HMS PP) in Germany highlights the growing industry focus on sustainable medical plastic solutions. Increasing regulatory emphasis on environmentally responsible healthcare materials and rising demand for recyclable polymers are expected to significantly support the growth of the recyclable medical polypropylene segment.
Medical-grade polymer compounds segment is expected to account for a major market share in 2026
Medical-grade polymer compounds are expected to hold a major market share in 2026 owing to the increasing production of advanced healthcare devices, diagnostic equipment, and pharmaceutical packaging systems requiring high-performance polymer materials. These compounds offer critical properties such as biocompatibility, sterilization resistance, and mechanical stability for medical manufacturing applications. The agreement signed between Formerra and GEON Performance Solutions in January 2026 to distribute Foster® medical compounds throughout Europe reflects the growing expansion of medical-grade polymer supply chains across the European healthcare sector. Rising investments in healthcare infrastructure and increasing medical device manufacturing activities are expected to further accelerate the adoption of medical-grade polymer compounds.
Cleanroom medical injection molding segment is expected to account for a major market share in 2026
Cleanroom medical injection molding solutions are expected to hold a major market share in 2026 due to the increasing demand for contamination-controlled manufacturing processes in medical device and healthcare product production. These systems are extensively used to manufacture precision plastic components for surgical devices, diagnostics, drug delivery systems, and implantable products within regulated cleanroom environments. The acquisition of Denmark-based medical injection molder Knudsen Plast A/S by MGS Healthcare Manufacturing in February 2026 highlights the growing strategic focus on expanding cleanroom molding capacity and healthcare plastics manufacturing operations across Europe. Increasing demand for high-quality medical plastic components and rising outsourcing of healthcare manufacturing operations are expected to significantly contribute to segment growth.
Bioresorbable medical polymers segment is expected to account for a major market share in 2025
Bioresorbable medical polymers are expected to hold a major market share in 2025, primarily driven by the growing use of implantable and biodegradable materials in orthopedic, dental, and advanced medical device applications. These polymers are designed to safely degrade within the body over time, eliminating the need for secondary surgical removal procedures while supporting tissue healing and regeneration. The strategic distribution agreement entered into by Evonik and IMCD in July 2025 for RESOMER® bioresorbable medical device polymers across Europe reflects the increasing adoption of advanced implantable medical plastics. Expanding applications in orthopedic devices, dental meshes, and 3D-printed implants are expected to significantly support the growth of the bioresorbable medical polymers segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404